+85.2%
GSK vs GGLL
+328.7%
-243.5%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GGLL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -2.3% | +0.4% | -1.9% |
| 7D | -1.8% | -4.8% | +2.9% | -1.7% |
| 30D | -2.2% | -13.7% | +11.5% | -1.9% |
| 3M | -1.8% | -21.9% | +20.0% | -1.5% |
| 6M | -10.6% | +11.7% | -22.3% | -11.0% |
| YTD | +4.4% | +2.3% | +2.1% | +4.0% |
| 1Y | +30.4% | +76.2% | -45.8% | +29.3% |
| 3Y | +60.1% | +245.0% | -184.9% | +54.0% |
| All | +85.2% | +328.7% | -243.5% | +81.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GGLL.
Daily Out/Under-Performance
Portfolio return minus GGLL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GGLL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GGLL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling